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Abstract
Motivation: MicroRNAs (miRNAs) are short single-stranded non-coding molecules
that usually function as negative regulators to silence or suppress gene expres-
sion. Due to interested in the dynamic nature of the miRNA and reduced microar-
ray and sequencing costs, a growing number of researchers are now measuring
high-dimensional miRNAs expression data using repeated or multiple measures
in which each individual has more than one sample collected and measured over
time. However, the commonly used site-by-site multiple testing may impair the
value of repeated or multiple measures data by ignoring the inherent dependent
structure, which lead to problems including underpowered results after multiple
comparison correction using false discovery rate (FDR) estimation and less bi-
ologically meaningful results. Hence, new methods are needed to tackle these
issues.
Results: We propose a penalized regression model incorporating grid search
method (PGS), for analyzing association study of high-dimensional microRNA
expression data with repeated measures. The development of this analytical frame-
work was motivated by a real-world miRNA dataset. Comparisons between PGS
and the site-by-site testing revealed that PGS provided smaller phenotype predic-
tion errors and higher enrichment of phenotype-related biological pathways than
the site-by-site testing. Simulation study showed that PGS provided more ac-
curate estimates and higher sensitivity than site-by-site testing with comparable
specificities.
Availability: R source code for PGS algorithm, implementation example, and
simulation study are available for download at https://github.com/feizhe/PGS.
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Motivation: MicroRNAs (miRNAs) are short single-stranded non-coding molecules that 
usually function as negative regulators to silence or suppress gene expression. Due to 
interested in the dynamic nature of the miRNA and reduced microarray and sequencing 
costs, a growing number of researchers are now measuring high-dimensional miRNAs 
expression data using repeated or multiple measures in which each individual has more 
than one sample collected and measured over time. However, the commonly used site-by-
site multiple testing may impair the value of repeated or multiple measures data by 
ignoring the inherent dependent structure, which lead to problems including 
underpowered results after multiple comparison correction using false discovery rate 
(FDR) estimation and less biologically meaningful results. Hence, new methods are 
needed to tackle these issues. 
Results: We propose a penalized regression model incorporating grid search method 
(PGS), for analyzing association study of high-dimensional microRNA expression data 
with repeated measures. The development of this analytical framework was motivated by 
a real-world miRNA dataset. Comparisons between PGS and the site-by-site testing 
revealed that PGS provided smaller phenotype prediction errors and higher enrichment of 
phenotype-related biological pathways than the site-by-site testing. Simulation study 
showed that PGS provided more accurate estimates and higher sensitivity than site-by-
site testing with comparable specificities.  
Availability: R source code for PGS algorithm, implementation example, and simulation 
study are available for download at https://github.com/feizhe/PGS. 
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1 INTRODUCTION  
MicroRNAs (miRNAs) are short single-stranded RNAs of nearly 20-24 nucleotides in length that 
are transcribed from DNA but not translated into proteins (Singh, et al., 2008). Most miRNAs 
inhibit the translation of proteins, destabilize their target mRNAs, and control many cellular 
mechanisms dynamically (Baek, et al., 2008; Selbach, et al., 2008). Even small changes in 
miRNA expression levels may have profound consequences for the expression levels of target 
genes (Reinsbach, et al., 2012). The dynamic nature of miRNAs distinguishes it from genetics. 
Therefore, due also to reduced microarray and sequencing experiments cost, a growing number of 
researchers are conducting investigations that measure high-dimensional miRNAs expression 
data using repeated or multiple measures in which each individual has more than one sample 
collected and measured over time (Chen, et al., 2013; Hecker, et al., 2013). Repeated or multiple 
measures data allow the researcher to exclude miRNA expression variation between individuals 
depending on the outcomes and pinpoint the causal role of miRNA expressions such as 
longitudinal study design.  
The popular site-by-site testing using Generalized Estimation Equation (GEE) (Zeger, et al., 
1988) or Linear Mixed Model (LMM) (Henderson, et al., 1959) represents a feasible approach to 
accommodate the presence of high-dimensional miRNA expression data measured at different 
time points. Site-by-site testing is a type of analysis that performs univariate tests of associations 
for each of the biomarker sites, followed by multiple-testing adjustments, for example, the 
Bonferroni’s p-value correction or the false discovery rate (FDR) q-value (Storey and Tibshirani, 
2003). However, this approach is particularly problematic in high-dimensional miRNA 
expression data, because it ignores the underlying dependent structure between miRNAs. In 
addition, not like genetics, miRNA expressions are modifiable by environmental factors including 
diet, air pollution, and other external exposures (Hamm, et al., 2010). Hence, for better 
delineation of the direct effects of miRNAs, adjusting for these environment factors in models are 
recommended (Rakyan, et al., 2011). But issues such as overfitting, collinearity, and obscuring 
biomarkers with small effect sizes are usually encountered in typical regression approaches, e.g. 
GEE and LMM. Therefore, computationally feasible methods are required to tackle these 
problems.  
We propose to apply a variable selection method with specific application in high-dimensional 
miRNA expression data with repeated or multiple measures. Wang et al. proposed a novel 
penalized GEE (PGEE) (Wang, et al., 2012) method to select variables when the number of 
covariates is moderate in a repeated or multiple measures setting. PGEE is able to account for 
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both within subject correlation and dependencies between different biomarkers. However, PGEE 
typically fails in the presence of high-dimensional biomarkers, i.e. when the number of 
biomarkers is larger than the sample size. To tackle this issue, we developed a pre-screening-
based PGEE with grid search method (PGS). Our method consists of an iterative two-step 
approach. Step 1, uses the screening method to downsize the biomarkers, while step 2 feeds the 
“survived” biomarkers to the PGEE. We repeat these two steps in a grid search and perform K-
fold cross validation to determine tuning parameters.  
We test our methods in a miRNA profiling dataset generated from our Beijing Truck Driver Air 
Pollution Study (BTDAS) (Baccarelli, et al., 2011; Byun, et al., 2013; Guo, et al., 2014; Hou, et 
al., 2012; Hou, et al., 2013; Hou, et al., 2013). In BTDAS, we measured air pollution and health 
outcomes, including lung functions, twice with 1-2 weeks apart. We also collected blood samples 
twice for biomarker measurements, including miRNA profiling.  
Based on repeated measures miRNA collected in BTDAS, we apply PGS to model the lung 
function levels measured by forced expiratory volume in 1 second (FEV1), with the goal of 
detecting lung function related miRNAs and uncovering regulatory pathways. We also compare 
PGS with GEE and LMM site-by-site testing in terms of prediction error of lung function levels 
and enrichment of lung function related biological pathways. In addition, a simulation study is 
conducted to examine the extensions of PGS. 
2 METHODS 
2.1 Penalized Generalized Estimating Equations (PGEE) 
PGEE (Wang, et al., 2012) can be used for analyzing repeated or multiple measurement data with 
moderate number of covariates. The algorithm is able to select non-zero effects among a number 
of predictors via adding penalty terms to the traditional GEE. The penalized generalized 
estimating functions U(β) are defined as below:  
U(β) = S(β) - qλ(|β|)sign(β) 
where S(β) are the estimating functions defining a GEE; qλ(|β|) are the penalty functions that 
introduce penalties to each of non-zero β estimate, so that if certain true βi are zero, the algorithm 
would force the estimates to be zeroes; sign(β) is the sign vector for β. Tuning parameter λ within 
the penalty functions qλ(|β|), is the coefficient of penalty terms and it determines the amount of 
shrinkage, i.e., bigger λ leads to smaller overall size of estimated effects. In order to select the 
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effect size that best fits the data, λ will be tuned among a sequence of candidate values using K-
fold cross validation. 
2.2 PGEE with Grid Search (PGS) 
In order to enhance the reliability of PGEE selection result, we perform PGEE on a sequence of 
subsets of the biomarkers based on the ranking of significance (e.g., p-values) obtained by a 
univariate pre-screening analysis adjusted for confounders. Each time a certain number of top 
biomarkers (denoted as Pm) enter the PGEE model. Pm becomes a tuning parameter and constitute 
a searching grid together with PGEE penalty parameter λ. By running PGEE throughout all 
parameter pairs (Pm, λ) in the grid, the best pair would be achieved in terms of the smallest 
prediction error calculated by 20-fold cross validation. With the best parameter pair setting, 
biomarkers with absolute coefficient (β) estimates > 0.001 were selected as influential 
biomarkers. 
2.3 Model Comparison between PGS and GEE/LMM 
Two evaluation matrices were considered in model comparison: phenotype prediction 
performance and enrichment of phenotype-related biological pathway. 
2.3.1 Phenotype prediction performance Smaller prediction error indicates better phenotype 
prediction performances and thus higher value of disease diagnosis using the biomarkers selected 
from a model. To obtain comparable prediction errors between PGS and site-by-site testing, the 
10-fold cross validation procedure used in PGS was implemented to site-by-site testing. 
2.3.2 Enrichment of phenotype-related biological pathway A higher enrichment of biological 
pathway suggests that the sites selected from a model is biologically plausible. MiRNA pathway 
enrichment analysis was conducted using DIANA-mirPath v2.0 (Vlachos, et al., 2012) 
(http://www.microrna.gr/miRPathv2), a web-based computational tool incorporating an in silico 
miRNA target prediction tool using high prediction accuracy algorithm DIANA-microT-CDS 
(Paraskevopoulou, et al., 2013). Gene union set targeted by at least one selected miRNA were 
identified. MiRNA and pathway related information was obtained from miRBase 18 (Kozomara 
and Griffiths-Jones, 2011) and KEGG v58.1 (Kanehisa, et al., 2012), respectively. To define a 
reliable miRNA-gene target prediction, microT score threshold > 0.9 was used in DIANA-
microT-CDS such that the miRNA-predicted genes were also predicted by miRanda (John, et al., 
2004) and/or TargetScan 5.0 (Friedman, et al., 2009). For enrichment tests, we applied Fisher's 
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Exact test based on jackknifing the test's probability (Hosack, et al., 2003), which is more 
conservative than Fisher's Exact test so that pathways with fewer targeted genes are penalized. 
The Benjamini and Hochberg false discovery rate (FDR) (Benjamini and Hochberg, 1995) was 
calculated to adjust for multiple hypothesis testing. Signaling pathways that have been shown to 
be associated with lung function were identified (Zander, et al., 2007). The enrichment of lung 
function related signaling pathway were quantified using negative log10 of the FDR. 
2.4 Beijing Truck Driver Air Pollution Study 
The Beijing Truck Driver Air Pollution Study (BTDAS), conducted between June 15 and July 27, 
2008, included participants with high exposure to air pollution in Beijing. All participants were 
examined on two separate examination days with 1-2 weeks apart. Detailed study design and data 
measurements were described previously (Baccarelli, et al., 2011). Lung function was quantified 
by forced expiratory volume in 1 second (FEV1) on both examination days. Total RNA was 
extracted from peripheral blood collected from each participant on both examination days. For 
better delineation of the direct effects of miRNAs, 10 potential confounders including PM2.5, sex, 
age, BMI, smoking status, usage of central heating, commuting time, working hours per day, dew 
point, and temperature were adjusted in lung function in GEE/LMM site-by-site testing and PGS. 
3 RESULTS 
3.1 MiRNA Profiling Data 
We conducted miRNA analysis on 240 blood samples collected at two examination days 
separated by a 1-2 week interval from 120 study subjects (sample size n=120). Detailed miRNA 
extraction and profiling data preprocessing can be found in the Supplementary Material. After 
normalization and background correction, 568 miRNAs with complete zero expression level 
across all 240 blood samples were removed, leaving 166 valid miRNAs together with the 10 
potential confounders in the final dataset.  
3.2 Identification of Lung-function Related MiRNAs with GEE/LMM Site-by-site Testing 
GEE and LMM site-by-site testing with adjustment of 10 confounders were applied to each of the 
166 miRNAs. Two widely used p-value adjustment methods for multiple comparisons, Benjamini 
and Hochberg False Discovery Rate (BH-FDR) (Benjamini and Hochberg, 1995) and FDR q-
value (Storey, 2002), were calculated to account for multiple testing. Only one miRNA from 
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LMM site-by-site testing was significant using the conventional significant threshold level of 5% 
FDR (Supplementary Material Table S1).
3.3 Identification of Lung-function Related MiRNAs Selection with PGS
Before running PGS, all 166 miRNAs were standardized
deviation of one. The ranking of miRNA significance was from a univariate pre
adjusted for confounders using either GEE or LMM. Starting from the top 10 miRNAs, we 
increased the number of top Pm 
miRNAs for PGS (Pm = 10, 30, …, 150) and one additional set of whole miRNAs (P
Penalty parameter λ varied from 0.06 to 0.24 by an increment of 0.02. To evaluate the reliability 
of the results, we repeated the above procedure for eight times. We found LMM
more stable, as six out of eight repeats yielded the same 10 selected influential miRNAs related to 
lung function with Pm = 110 and 
consistency across the eight repeats (Supplementary Material Table S2). The prediction error grid 
of LMM-based PGS was represented by a heat map shown in Fig. 1.
 
 
Fig. 1. Heat map of the 20-fold prediction errors from LMM
represents a PGEE prediction error under the corresponding parameter pair (P
Best selection results were achieved when incorporating top 110 miRNAs (P
LMM prescreening model with PGEE penalty paramete
3.4 Model Comparison between PGS and GEE/LMM Site
 
 
 with mean of zero and standard 
-screening model 
miRNAs by an increment of 20, resulting in eight subsets of input 
-based PGS were 
λ = 0.14, while GEE-based PGS selection results showed less 
 
-based PGS. Each grey
m, λ
m = 110) defined by 
r λ = 0.14.  
-by-site Testing 
m = 166). 
-scale block 
) in the grid. 
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3.4.1 Lung function prediction performance  For the purpose of model comparison, we 
selected a sequential number of the top ranking (top 5, 10, 15, and 20) miRNAs based on p-values 
as the identified miRNAs using site-by-site testing. Comparing with the lowest prediction errors 
of site-by-site testing which were achieved using the top 10 miRNAs (mean error = 5.4 for GEE 
and 6.1 for LMM), paired t-tests showed that PGS yielded a significantly lower prediction error 
(mean error = 5.3) (Table 1). 
Table 1. Comparison of phenotype prediction performance between GEE/LMM site-by-site 
testing and PGS.  
Mean prediction errors were computed 
by 10-fold cross validation errors from 
50 repeats. The 10 influential miRNAs 
selected by LMM-based PGS were used 
to calculate the prediction errors. P-
values were calculated by paired t-tests 
between the lowest prediction errors 
from GEE/LMM using top 10 miRNAs 
and the prediction errors from PGS 
using the selected 10 influential 
miRNAs. 
 
 
3.4.2 Enrichment of lung-function related biological pathways  We further evaluated 
enrichment of phenotype-related biological pathways of both PGS and site-by-site testing. Seven 
lab-proven KEGG signaling pathways related to lung function were identified (Zander, et al., 
2007). The 10 influential miRNAs selected by LMM-based PGS were used to represent the PGS 
approach. We also chose the top 10 miRNAs from GEE and LMM site-by-site testing, 
respectively, so that the three approaches yielded comparable amount of target genes. MiRNAs 
identified by all three approaches were significantly enriched in mTOR, PI3K-Akt, ErbB, Wnt, 
and MAPK signaling pathways. In general, enrichment of the genes targeted by miRNAs from 
Method 
Mean Prediction Errors 
GEE LMM 
Site-by-site testing   
     Top 5 miRNAs 5.5 5.6 
     Top 10 miRNAs 5.4 6.1 
     Top 15 miRNAs 5.7 6.2 
     Top 20 miRNAs 5.9 6.1 
PGS (LMM based) 5.3 
P-value <0.001 <0.001 
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PGS was higher than GEE site
testing (Fig. 2), indicating miRNAs selected by PGS were more biologically plausible.
Fig. 2. Enrichment of PGS vs GEE/LMM selected miRNA
signaling pathways related to lung function. PGS selection results were from LMM
 
True effects SBS # of 
selections 
SBS mean 
estimates 
GEE SBS and GEE-based PGS
0.1 1 0.73 
-0.2 12 -0.42 
0.3 27 0.48 
-0.4 57 -0.46 
0.5 76 0.55 
-0.6 95 -0.62 
0.7 99 0.70 
-0.8 99 -0.82 
0.9 100 0.89 
-1.0 100 -1.00 
Sensitivity 0.67  
Specificity 0.95  
RMSE  0.22 
Table 2. Performances of PGS and site
miRNAs, samples size of 120, and 10 non
 
-by-site testing, and considerably higher than LMM site
 among seven lab-proven KEGG 
-
PGS # of 
selections 
PGS mean 
estimates 
SBS # of 
selections 
SBS mean 
estimates 
 LMM SBS and LMM
4 0.10 3 0.37 
53 -0.18 5 -0.47 
93 0.27 29 0.46 
98 -0.38 51 -0.50 
100 0.50 81 0.52 
100 -0.59 95 -0.59 
100 0.69 100 0.71 
100 -0.8 100 -0.81 
100 0.89 100 0.91 
100 -0.99 100 -0.98 
0.85  0.66  
0.95  0.96  
 0.01  0.14 
-by-site testing (SBS) in simulation study with 200 
-zero true effects (Scenario I). 
-by-site 
 
based PGS. 
PGS # of 
selections 
PGS mean 
estimates 
-based PGS 
7 0.16 
70 -0.15 
94 0.27 
100 -0.39 
100 0.49 
100 -0.60 
100 0.69 
100 -0.80 
100 0.89 
100 -0.98 
0.87  
0.95  
 0.03 
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Mean estimates were calculated from the 100 simulation runs, respectively. Number of selections 
were the number of times each true effect selected by models out of the 100 runs. Sensitivity and 
specificity for each method were the average for all 100 runs. RMSE is root mean square error 
between mean estimates and true effects, which describes mean accuracy of the model estimates.  
3.5 Simulation Study 
A simulation study was conducted to compare the performance of PGS and site-by-site testing. 
Scenario I was comparable to the BTDAS miRNA dataset we studied with sample size n=120 
subjects and number of miRNAs p=200. Scenario II had a higher number of miRNAs p=800 but 
smaller sample size n=60. We assumed that there were five percent of miRNAs with true non-
zero effects (i.e. 10 for scenario I and 40 for scenario II). Corresponding 10 times 10 tuning 
parameter grids were set, Pms = (20, 40, ..., 200) and λs = (0.01,0.025,...,0.145) in scenario I and 
Pms = (10, 20, ..., 100) and λs = (0.01, 0.025, ..., 0.145) in scenario II. Pm > 100 in scenario II will 
not yield reliable selection results due to the relatively small sample size.  
Performance of GEE/LMM site-by-site testing as well as GEE-based and LMM-based PGS under 
scenario I was shown in Table 2. Scatterplot of receiver operating characteristic (ROC) can be 
found in Supplementary Material Figure S1. PGS had over 90% chance to identify effect with 
size as small as 0.3 while site-by-site testing was good till effect size is about 0.6. Moreover, PGS 
provided more accurate estimates even for small effects. On average PGS estimates only had 0.01 
and 0.03 deviation from the true effects in GEE-based and LMM-based PGS, respectively. PGS 
gave a much higher sensitivity (> 0.80) than site-by-site testing with comparable specificity (> 
0.95). For scenario II, due to the difficulties in detecting 40 non-zero miRNA with sample size of 
80, both site-by-site testing and PGS methods did not perform ideally. However, there was still 
significant gain from PGS over site-by-site testing (Supplementary Material Table S3 and Figure 
S1-c, S1-d).   
4 DISCUSSION 
In this study, we proposed and applied PGS method to handle high-dimensional microRNA 
expression data with repeated measures. We compared performances of the PGS and the 
traditional site-by-site testing. PGS performed consistently better than GEE/LMM site-by-site 
testing in terms of higher phenotype prediction performance and higher enrichment of phenotype-
related biological pathway. One of the regularity conditions for PGEE algorithm is that p=O(n), 
which requires the number of predictors (p) in model, should be comparable to the sample size 
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(n). To ensure the tuning penalty parameter (λ) yields an overall effect size estimation that best 
fits the data and avoid exceeded number of input biomarkers (Pm) for PGEE algorithm, we 
incorporated the grid search method. A 20-fold cross validation was implemented to determine 
the best PGEE selection results in terms of the smallest prediction error among the parameter 
searching grid (Pm, λ). PGS is a data-driven and self-training analytical framework that can 
achieve maximum data utilization while constraining model complexity simultaneously.  
One key merit of PGS is its capacity to handle a multitude of biomarkers at the same time and 
select the influential ones. Using site-by-site testing, we only found few “significant” results after 
having corrected for a high number of multiple testing. While using PGS, we identified a set of 
influential and meaningful miRNAs without encountering multiple testing issues, which offers a 
novel perspective in analyzing high-dimensional data with repeated measures. Another distinct 
advantage of PGS is that it considers all informative biomarkers as a whole instead of treating 
them individually. Using the site-by-site testing, although some miRNAs successfully pass the 
multiple testing, it is possible that meaningful biological events might not even be detected due to 
the correlations and interactions among miRNAs. However, the effects of these biomarkers could 
be significant when modeled together. PGS is able to capture these complex features across all 
input biomarkers and detect influential ones that site-by-site testing would potentially ignore.  
It is worth noting that PGS does not provide exact p-values, since the estimates do not follow 
normal distribution under the null hypotheses. Therefore, the criterion for determining influential 
biomarker in PGS is not based on p-value, but on the threshold for coefficient (β) estimates of 
biomarkers. Influential biomarkers are selected when the estimates are greater than the threshold. 
As suggested in Wang’s paper (Wang, et al., 2012), the default threshold is 0.001, which is also 
proved to be a practical and robust threshold in our simulation study in terms of sensitivity and 
specificity. To ensure that the threshold of 0.001 works uniformly for any dataset, standardizing 
each of the biomarkers with mean of zero and standard deviation of one is required as a typical 
procedure before running penalize model.  
Robust selection of biomarkers by PGS relies on the setting of grid boundary and grid resolution. 
Too large λ would shrink all beta estimates to zero while too small λ would not shrink the 
estimates at all. Based on our experience in real world data analyses and simulation studies, λ 
varied from 0.01 to 0.30 is a sufficient boundary that can cover optimal λ for most of the cases. 
Also, within this boundary, an increment of 0.02 in λ provides a proper grid resolution to capture 
subtle effect changes of λ on biomarker selection results without bringing in too much 
computational burden. As for Pm, too large Pm is overwhelmed for PGS to handle while too small 
Pm will leads to insufficient exploitation of data. Thus, usually optimal Pm can be found around 
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the sample size. This is the case in our miRNA study example where the optimal Pm=110 and 
with the addition of 10 adjusting confounders, we have the same number as the sample size n = 
120. Besides, an increment of 10 or 20 in Pm also provides sufficient resolution for capturing the 
effects of increasing Pm on biomarker selection. For practical use, the initiation of λ vector can be 
varied from 0.01 to 0.30, and the initiation of Pm can be a vector with a few numbers varied 
around the sample size minus the number of confounders (in our case, it is 120 - 10 = 110). It is 
not necessary to initiate a full vector of Pm, as it adds redundant parameter pairs to the grid. 
Extension of λ boundary and/or Pm boundary will be considered only when optimal λ and/or Pm 
hit the initial boundaries. In this paper we used different elaborate λ boundaries (but all were 
within the 0.01 to 0.30 range) for better results representations, and higher grid resolution (i.e. 
smaller increment of λ) for more reliable method evaluations in simulation studies. 
Insensitive to mis-specification of the covariance structure is a feature that distinguishes GEE 
from LMM. Inheriting this feature from GEE, PGS is able to estimate the correlation matrix 
regardless of whether or not the structure is specified. Based on the estimation, one could either 
use LMM-based PGS with a solid guess of the covariance structure or use GEE-based PGS if 
there is no good choice of the structure.  
Pre-screening step prioritizes potentially influential biomarkers, which facilitates PGS to handle 
the situation in which the number of biomarkers is considerably larger than the sample size. GEE 
and LMM are two handy approaches for pre-screening. However, the potential limitation of pre-
screening is that miRNAs with small but true non-zero effects may be excluded during the pre-
screening step. Nevertheless, with a given sample size, the grid search method in PGS ensures 
that PGEE can include as many biomarkers as possible. Another drawbacks of PGS is the 
selection results may subject to unreproducible selection results especially when sample size are 
small. This problem can be eased by using larger k-fold cross validation and higher grid 
resolution. 
5 CONCLUSION 
The performances of PGS is comparable to the approaches being benchmarked, i.e., site-by-site 
GEE/LMM. However, PGS is more suitable for high-dimensional microRNA expression data 
with repeated measures in that, by exploiting underlying dependent structures, it relies on variable 
selection in the context of a multiple regression model, which circumvents multiple testing issues. 
PGS is also applicable to other longitudinally collected high-dimensional quantitative data, such 
as, epigenomics, mRNA transcriptomics, proteomics, metabolomics, etc. The growing number of 
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studies conducting high-dimensional profiling dataset using different platforms requires a more 
comprehensive evaluation of PGS in various study settings. 
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